SCHEMBL27154398

SCHEMBL27154398

O=C([C@@H]1CCCN1C(=O)O)N1CC2CCC(C1)N2C(=O)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27340900 0.84 HSD17B10 (0.55) —
SCHEMBL28218046 0.77 — —
Hydrochloric Acid SCHEMBL30020095 0.76 UCHL1 (0.46) —
SCHEMBL27340905 0.73 PARP1 (0.45) —
SCHEMBL20482097 0.73 ALDH1A1 (0.49) —
SCHEMBL3001673 0.73 ALDH1A1 (0.49) —
SCHEMBL20482428 0.73 ALDH1A1 (0.49) —
Hydrochloric Acid SCHEMBL27142179 0.72 PARP1 (0.44) —
SCHEMBL13229 0.70 CA2 (0.67) —
SCHEMBL13230 0.70 CA2 (0.67) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217978-A1 COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2024-07-04 — — US disclosed
EP-4326724-A1 COMPOUND AS ADENOSINE A2A RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2024-02-28 — — EP disclosed
Send feedback